Epidemiology
A low- to intermediate-grade malignant vascular neoplasm that can affect soft tissue or bone. It can be multifocal within the musculoskeletal system; the initial extent guides surveillance and treatment.
Basic features
It can be multifocal and follow an unpredictable course, with pain or a mass depending on the site. It is confirmed by the characteristic WWTR1-CAMTA1 fusion (or YAP1-TFE3 in a minority), a key finding because its epithelioid appearance can be mistaken for a metastatic carcinoma.
Usual treatment
Management ranges from observation in selected cases to surgery, radiotherapy, or systemic treatment depending on the extent and symptoms.
Outcomes and prognosis
The course may be slow or progressive; the prognosis is variable — often intermediate-favorable, but worse with extensive disease. The size, symptoms, and extent guide follow-up.
